Clinical Trial Update: The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE [Phase 3]

View source ↗

Summary

Phase 3 LATITUDE study reports results for a long-acting HIV therapy intended to improve daily treatment success; results were posted on 2025-04-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-24